Liner for cryogenic treatment systems
Liners for cryogenic treatment systems are described where a cryogenic fluid or gas may be introduced into a liner expanded within a body lumen such as the uterine cavity. The liner may be intentionally sized to be substantially larger than the typical size of the uterine cavity, e.g., 1.2 times (or more), greater than the size of the uterine cavity into which the liner is inserted. Because the liner is sized intentionally larger than the body lumen to be treated, the liner may never fully expand when deployed. But even with folds or portions of the liner being folded upon itself, the liner may remain sufficiently supple such that the resulting uncontrolled folds allow for complete conformance of the liner against the anatomy of the contacted tissue.
1. A method of treating tissue, comprising:
positioning an elongate probe into a uterine cavity to be treated, the elongate probe having a distal tip and a flexible length;
expanding a liner enclosing the probe from a delivery configuration to an expanded configuration, wherein:
in the delivery configuration, the liner is folded and collapsed along pre-formed folds or pleats within a sheath, and
in the expanded configuration, the liner is sized to be larger than the uterine cavity such that portions of the liner fold upon themselves in a controlled manner; and
infusing a cryoablative fluid through a delivery lumen slidingly positioned through or along an infusion lumen, wherein the infusion lumen defines one or more openings along its length and is positioned through or along the elongate probe such that the cryoablative fluid passes through one or more unobstructed openings and into contact with an interior of the liner,
wherein translation of the delivery lumen relative to the infusion lumen controls a number of unobstructed openings along the infusion lumen such that proximal translational of the delivery lumen relative to the infusion lumen from a first location increases the number of unobstructed openings, and distal translation of the delivery lumen relative to the infusion lumen from the first location decreases the number of unobstructed openings.
2. The method of claim 1 , wherein the portions are folded to form between 1 to 3 layers of the liner.
3. The method of claim 1 , wherein the portions are folded to a thickness of between 0.001 in to 0.003 in of the liner.
4. The method of claim 1 , wherein the delivery lumen comprises a Nitinol delivery tube slidingly positioned through the infusion lumen.
5. The method of claim 1 , wherein the cryoablative fluid infused through the delivery lumen is supplied by a reservoir of cryoablative fluid in fluid communication with the delivery lumen.
6. The method of claim 5 , wherein the cryoablative fluid comprises nitrous oxide or argon.
7. The method of claim 1 , wherein, in the expanded configuration, the liner forms a contoured shape which is at least 1.2 times greater than the uterine cavity.